NCT02704871 - The Ward Study for SeptiCyte® Lab to Distinguish Between Infection-positive and Infection-negative SIRS | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

February 28, 2018

Conditions

SepsisSIRS

Interventions

OTHER

SeptiCyte Lab molecular diagnostic test (non-interventional)

This is not an interventional study. Rather it involves evaluation of a molecular diagnostic test to distinguish between sepsis and infection-negative SIRS based on host response.

Trial Locations (1)

02903

Rhode Island Hospital, Providence